Related Experiment Videos
Polymyalgia rheumatica and temporal arteritis: managing older patients
Abstract:
PMR and GCA are diagnosed relatively frequently in the white geriatric population. Patients may suffer from both conditions or from either alone. PMR is considered a diagnosis of exclusion, with the most characteristic symptoms being profound morning stiffness affecting the hip and shoulder girdles. The diagnosis of PMR can be buttressed by the findings of an elevated ESR, anemia, and mildly elevated liver enzymes. PMR can be controlled with less than or equal to 20 mg/d of prednisone, whereas higher doses of glucocorticoids are required for GCA. Classic GCA is characterized by headache, visual changes, and constitutional symptoms. GCA can be confirmed by a biopsy revealing a histologic picture of granulomatous inflammation centered around the elastin of the involved vessel. Judicious efforts to taper steroids are indicated in both syndromes, but many patients require therapy for at least 2 years.
Insights
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are common in older white adults. While PMR is a diagnosis of exclusion, GCA presents with distinct symptoms and requires confirmation via biopsy.
Area of Science:
- Rheumatology
- Geriatric Medicine
- Internal Medicine
Background:
- Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are inflammatory conditions frequently diagnosed in the white geriatric population.
- Patients may present with either PMR or GCA, or concurrently with both.
- PMR is characterized by profound morning stiffness in the hip and shoulder girdles and is a diagnosis of exclusion.
Purpose of the Study:
- To differentiate the diagnostic criteria and treatment approaches for PMR and GCA.
- To highlight key clinical and laboratory findings for each condition.
- To inform on the typical duration of steroid therapy required for management.
Main Methods:
- Review of clinical presentations and diagnostic findings for PMR and GCA.
- Comparison of laboratory markers, including erythrocyte sedimentation rate (ESR), anemia, and liver enzymes.
- Analysis of characteristic symptoms and biopsy findings for GCA.
- Evaluation of typical prednisone dosages for PMR versus GCA management.
Main Results:
- PMR diagnosis is supported by elevated ESR, anemia, and mildly elevated liver enzymes, with morning stiffness as a key symptom.
- GCA presents with headache, visual changes, and constitutional symptoms, confirmed by biopsy showing granulomatous inflammation.
- PMR is managed with ≤20 mg/d prednisone, while GCA requires higher glucocorticoid doses.
Conclusions:
- Effective management of PMR and GCA involves appropriate steroid dosing tailored to each condition.
- Long-term steroid therapy, often for at least two years, is frequently necessary for both syndromes.
- Judicious steroid tapering is a critical component of managing these inflammatory conditions.